Replies to post #126893 on Biotech Values

[DewDiligence]

I certainly don't know of any generic drug companies sub $250M enterprise value that have better prospects.

That’s not what I asked—I asked if there was any biotech company of any kind with a $250M enterprise value and better prospects than MNTA. If there is, I’d like to know about it!